Methylphenidate HCL ER Tablets

Subject: Methylphenidate HCL ER Tablets
Solicitation Number: SPE2D2-24-R-0014
Notice Type: PRESOL
NAICS: 325412
Notice Published: 05-14-24

Contact: Courtney Hunter-Stangler This email address is being protected from spambots. You need JavaScript enabled to view it. Ph: (215) 737-6845
Office Address: PHILADELPHIA, PA 19111

Click for official SAM (FBO) notice, additional information, and accompanying attachments

The Defense Logistics Agency isplanning to issue asolicitation for a national requirements contract for Methylphenidate HCL ER Tablets. Procurement details follow. Methylphenidate HCL ER: 10MG and 20MG tablets in 100 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at and at Interested parties should contact Courtney Hunter-Stangler at (215) 737-6845 or This email address is being protected from spambots. You need JavaScript enabled to view it. for any questions/comments. Interested parties are further advised toset up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is June of 2024. DLA reserves the right to issue the solicitation before or after the projected solicitation date.